MULTI EXPRESS ZERTIFIKAT - DEUTSCHE BANK/ROCHE GS Share Price

Certificat

CH1248692662

Market Closed - Deutsche Boerse AG 16:28:01 17/05/2024 BST
976.3 EUR +0.50% Intraday chart for MULTI EXPRESS ZERTIFIKAT - DEUTSCHE BANK/ROCHE GS
Current month+7.47%
1 month+8.70%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
17/05/24 976.3 +0.50%
16/05/24 971.4 +2.07%
15/05/24 951.7 +1.58%
14/05/24 936.9 -1.13%
13/05/24 947.7 +0.68%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 04:28 pm

More quotes

Static data

Product typeOther Certificates
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer LEONTEQ
WKN A2U1RC
ISINCH1248692662
Date issued 22/02/2023
Strike 279.2 CHF
Maturity 15/02/2027 (1004 Days)
Parity 0.28 : 1
Emission price 1,000
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 1,060
Lowest since issue 758.8
Spread 7.35
Spread %0.75%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus